| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 19 |
| 1 | RITUXIMAB | 14 |
| 2 | FINGOLIMOD HCL | 6 |
| 3 | LAMOTRIGINE | 6 |
| 4 | METHOTREXATE | 6 |
| 5 | METHOTREXATE SODIUM | 6 |
| 6 | CARBAMAZEPINE | 5 |
| 7 | LAMOTIRIGINE | 5 |
| 8 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 5 |
| 9 | LAMOTRIGINE EXTENDED-RELEASE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOMELOTINIB | 2 | 0.0014 |
| 1 | DANTROLENE SODIUM | 1 | 0.0009 |
| 2 | SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM | 1 | 0.0007 |
| 3 | GLOFITAMAB | 1 | 0.0004 |
| 4 | PRASTERONE | 1 | 0.0004 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 6 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 1 | 0.0004 |
| 7 | OCRELIZUMAB | 19 | 0.0003 |
| 8 | IDELALISIB | 2 | 0.0003 |
| 9 | FLUVASTATIN SODIUM | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 31 | 0.0001 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 7 | Mood Stabilizer [EPC] | 12 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Integrin Receptor Antagonist [EPC] | 4 | 0.0000 |